PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (Nasdaq:BJGP) today announced that it has signed an exclusive license agreement with Shanghai Ethypharm Pharmaceutical Co., Ltd., a subsidiary of the French drug delivery company Ethypharm, under which Beijing Med-Pharm will market and distribute ondansetron Flashtab® (4 and 8 mg) in the People’s Republic of China.